Skip to main content
. 2020 Jan 13;2020(1):CD012643. doi: 10.1002/14651858.CD012643.pub3

De Rueda 2013.

Notes Title: Prognostic value of 18F‐FDG PET‐CT in Hodgkin lymphoma.
(Conference abstract)
Aim

  • To determine the value of 18F‐FDG PET‐CT after the second and sixth cycle of first line therapy with ABVD or BEACOPP in the outcome of individuals with HL


Study design

  • Retrospective, January 2007 to December 2012


Country/treatment centre(s)

  • Spain


Number of included participants

  • 79


Inclusion criteria

  • HL diagnosis


Exclusion criteria

  • Not reported


Treatment

  • ABVD or BEACOPP


Primary outcome measure(s)

  • Progression‐free survival